β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether atypical antipsychotic drugs (commonly
prescribed for treating schizophrenia) induce changes in anthropometry and metabolism,
including alteration in insulin sensitivity and/or insulin secretion by the pancreas, when
given to lean, non-diabetic, individuals who are antipsychotic drug(s)-naïve, and free of
metabolic syndrome at enrollment.
Details
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain